Identifying and Networking with Industry: How to Market Your Research
Increasingly, academic researchers collaborate with industry in order to advance their research toward the market. Because there are many venues and routes to contact industry, it may appear bewildering to find the right approach.
This session will highlight, in about 1 hour including audience questions, proven strategies to assemble and prepare your research for an industrial audience. At the end of this hour, participants will recognize effective venues for networking with industry, a sharp approach to summarizing their proposition, and what to expect from the process of interacting with industry.
Participants who are seeking industrial or investor funding to advance their innovations are especially encouraged to attend.
CORBEL webinars include an audience Q&A session during which attendees can ask questions and make suggestions.
This webinar took place on 29 May 2017. The slides from this webinar can be downloaded from SlideShare here.
About the speakers...
Tim Moser is EATRIS industry partnering specialist. He was educated in biology, and later obtained an MBA in Supply Chain Management. His work experience includes basic scientific research in bacteriology and immunology, evolving into operations and site management in life sciences companies. Since 2010 he works in technology transfer and specializes in industry partnering in life sciences, pharma, and biotech.
As Director of Business Development for Industry Alliance Office of Amsterdam Neuroscience, Tim developed and negotiated collaboration agreements with companies including Avid, Biogen, Boehringer Ingelheim, EIP Pharma, GSK, IBL/Tecan, Janssen/J&J, Lysosomal Therapeutics, Medavante, Merck, Novartis, Ono, Probiodrug, Roche, Somalogic, and UCB. He specializes in identifying the frontier areas in academic translational medicine that spark intense interest for industry, and pursuing mutually beneficial routes toward partnership.
Kees de Ruig has an educational background in Medicinal Chemistry. After obtaining his Master’s at the Free University in Amsterdam, Kees got involved in clinical research. He has worked as a Project Manager at the phase 1 unit Pharma BioResearch (currently part of PRA) and then at the imaging corelab BioClinica. At BioClinica, Kees moved into a managerial role as the Manager of the Project Management Team. In 2014, Kees obtained his MBA with a thesis on 'Open Innovation in the Life Sciences'.
Kees joined EATRIS in 2015 as Business Development Manager. In this role, he is responsible for the development of partnerships between industry and academia. He interacts directly with industry but also with science parks, branch-organizations and investors. He strongly believes that innovation requires collaboration, and collaboration requires respect for the motivational drivers of the partners. A clear understanding of these drivers is the basis of the win-win solutions he fosters.
Nigel Wagstaff studied chemistry and worked for over 30 years for Shell in research, technology licensing and intellectual asset management. His research activities included work on refinery conversion processes, membrane separation, analytical chemistry and catalyst manufacture. In 1980 he transferred from the Amsterdam laboratory to the Shell central office in The Hague where he was involved in research planning and budgeting before moving to a marketing role in the licensing of Shell’s refining technology processes. The interest in licensing and intellectual property stayed with him throughout the rest of his career, with a final assignment as global Intellectual Asset Manager for Shell International Chemicals.
After retiring from Shell in 2015 Nigel joined the technology transfer office (now IXA) of the Amsterdam VU University and Medical Center, working as business development manager on licensing and spin-off ventures, mainly in physics, chemistry and life sciences. He was responsible for a number of licensing deals with industry parties and was involved in setting up several high-tech start-ups emerging from academic research and often assisted by entrepreneurs from outside academia.
Since 2015 he has been working as innovation advisor to EATRIS in Amsterdam, with special emphasis on the CORBEL innovation work package. In addition he does freelance work for other clients in innovation, technology transfer and marketing skills for scientists. Nigel has been a member of the Licensing Executives Society Benelux since 1991 and served between 1997 and 2006 on its board including spells as secretary and president. He is a member of the Royal Society of Chemistry (UK).